Harvard Bioscience
HBIO
HBIO
81 hedge funds and large institutions have $111M invested in Harvard Bioscience in 2020 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 30 increasing their positions, 27 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
Holders
81
Holding in Top 10
1
Calls
$4K
Puts
–
Top Buyers
| 1 | +$1.54M | |
| 2 | +$871K | |
| 3 | +$739K | |
| 4 |
BlackRock
New York
|
+$650K |
| 5 |
JPMorgan Chase & Co
New York
|
+$332K |
Top Sellers
| 1 | -$2.88M | |
| 2 | -$1M | |
| 3 | -$825K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$633K |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$424K |